BIOMAT Database Logo BIOMAT Database Logo

Glucose metabolism following liver transplantation and immunosuppression with cyclosporine A or FK 506. 1995

N Senninger, and M Golling, and K Datsis, and B Sido, and C Herfarth, and G Otto
Department of Surgery, University of Heidelberg, Germany.

UI MeSH Term Description Entries
D008297 Male Males
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D002096 C-Peptide The middle segment of proinsulin that is between the N-terminal B-chain and the C-terminal A-chain. It is a pancreatic peptide of about 31 residues, depending on the species. Upon proteolytic cleavage of proinsulin, equimolar INSULIN and C-peptide are released. C-peptide immunoassay has been used to assess pancreatic beta cell function in diabetic patients with circulating insulin antibodies or exogenous insulin. Half-life of C-peptide is 30 min, almost 8 times that of insulin. Proinsulin C-Peptide,C-Peptide, Proinsulin,Connecting Peptide,C Peptide,C Peptide, Proinsulin,Proinsulin C Peptide
D005260 Female Females
D005951 Glucose Tolerance Test A test to determine the ability of an individual to maintain HOMEOSTASIS of BLOOD GLUCOSE. It includes measuring blood glucose levels in a fasting state, and at prescribed intervals before and after oral glucose intake (75 or 100 g) or intravenous infusion (0.5 g/kg). Intravenous Glucose Tolerance,Intravenous Glucose Tolerance Test,OGTT,Oral Glucose Tolerance,Oral Glucose Tolerance Test,Glucose Tolerance Tests,Glucose Tolerance, Oral
D006442 Glycated Hemoglobin Products of non-enzymatic reactions between GLUCOSE and HEMOGLOBIN (occurring as a minor fraction of the hemoglobin of ERYTHROCYTES.) It generally refers to glycated HEMOGLOBIN A. Hemoglobin A1c (Hb A1c) is hemoglobin A with GLYCATION on a terminal VALINE of the beta chain. Glycated hemoglobin A is used as an index of the average blood sugar level over a lifetime of erythrocytes. Fructated Hemoglobins,Glycohemoglobin,Glycohemoglobin A,Glycohemoglobins,Glycosylated Hemoglobin A,Hb A1c,HbA1,Hemoglobin A(1),Hemoglobin A, Glycosylated,Glycated Hemoglobin A,Glycated Hemoglobin A1c,Glycated Hemoglobins,Glycosylated Hemoglobin A1c,Hb A1,Hb A1a+b,Hb A1a-1,Hb A1a-2,Hb A1b,Hemoglobin, Glycated A1a-2,Hemoglobin, Glycated A1b,Hemoglobin, Glycosylated,Hemoglobin, Glycosylated A1a-1,Hemoglobin, Glycosylated A1b,A1a-1 Hemoglobin, Glycosylated,A1a-2 Hemoglobin, Glycated,A1b Hemoglobin, Glycated,A1b Hemoglobin, Glycosylated,Glycated A1a-2 Hemoglobin,Glycated A1b Hemoglobin,Glycosylated A1a-1 Hemoglobin,Glycosylated A1b Hemoglobin,Glycosylated Hemoglobin,Hemoglobin A, Glycated,Hemoglobin A1c, Glycated,Hemoglobin A1c, Glycosylated,Hemoglobin, Glycated,Hemoglobin, Glycated A1a 2,Hemoglobin, Glycosylated A1a 1,Hemoglobins, Fructated,Hemoglobins, Glycated
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D016031 Liver Transplantation The transference of a part of or an entire liver from one human or animal to another. Grafting, Liver,Hepatic Transplantation,Liver Transplant,Transplantation, Hepatic,Transplantation, Liver,Hepatic Transplantations,Liver Grafting,Liver Transplantations,Liver Transplants,Transplant, Liver
D016559 Tacrolimus A macrolide isolated from the culture broth of a strain of Streptomyces tsukubaensis that has strong immunosuppressive activity in vivo and prevents the activation of T-lymphocytes in response to antigenic or mitogenic stimulation in vitro. Anhydrous Tacrolimus,FK-506,FK506,FR-900506,Prograf,Prograft,Tacrolimus Anhydrous,Anhydrous, Tacrolimus,FK 506,FR 900506,FR900506,Tacrolimus, Anhydrous
D016572 Cyclosporine A cyclic undecapeptide from an extract of soil fungi. It is a powerful immunosupressant with a specific action on T-lymphocytes. It is used for the prophylaxis of graft rejection in organ and tissue transplantation. (From Martindale, The Extra Pharmacopoeia, 30th ed). Cyclosporin A,Ciclosporin,CsA-Neoral,CyA-NOF,Cyclosporin,Cyclosporine A,Neoral,OL 27-400,Sandimmun,Sandimmun Neoral,Sandimmune,CsA Neoral,CsANeoral,CyA NOF,OL 27 400,OL 27400

Related Publications

N Senninger, and M Golling, and K Datsis, and B Sido, and C Herfarth, and G Otto
CMV infection in liver transplantation under cyclosporine or FK 506 immunosuppression.
December 1991, Transplantation proceedings,
N Senninger, and M Golling, and K Datsis, and B Sido, and C Herfarth, and G Otto
Randomized trial in primary liver transplantation under immunosuppression with FK 506 or cyclosporine.
February 1993, Transplantation proceedings,
N Senninger, and M Golling, and K Datsis, and B Sido, and C Herfarth, and G Otto
Interferon therapy of hepatitis following liver transplantation under FK 506 or cyclosporine.
December 1991, Transplantation proceedings,
N Senninger, and M Golling, and K Datsis, and B Sido, and C Herfarth, and G Otto
A comparison of tacrolimus (FK 506) and cyclosporine for immunosuppression in liver transplantation.
October 1994, The New England journal of medicine,
N Senninger, and M Golling, and K Datsis, and B Sido, and C Herfarth, and G Otto
A randomized trial of primary liver transplantation under immunosuppression with FK 506 vs cyclosporine.
December 1991, Transplantation proceedings,
N Senninger, and M Golling, and K Datsis, and B Sido, and C Herfarth, and G Otto
Nephrotoxic effects of primary immunosuppression with FK-506 and cyclosporine regimens after liver transplantation.
February 1994, Mayo Clinic proceedings,
N Senninger, and M Golling, and K Datsis, and B Sido, and C Herfarth, and G Otto
Comparative study of FK 506, cyclosporine, and triple regimen immunosuppression with FK 506, cyclosporine, and mizoribine.
December 1991, Transplantation proceedings,
N Senninger, and M Golling, and K Datsis, and B Sido, and C Herfarth, and G Otto
FK 506 primary immunosuppression following emergency liver transplantation for fulminant hepatic failure. European FK 506 Study Liver Group.
January 1994, Transplant international : official journal of the European Society for Organ Transplantation,
N Senninger, and M Golling, and K Datsis, and B Sido, and C Herfarth, and G Otto
Infections during a randomized trial comparing cyclosporine to FK 506 immunosuppression in liver transplantation.
February 1992, Transplantation proceedings,
N Senninger, and M Golling, and K Datsis, and B Sido, and C Herfarth, and G Otto
FK 506 versus cyclosporine in pediatric liver transplantation.
December 1991, Transplantation proceedings,
Copied contents to your clipboard!